Paratek Pharmaceuticals (FRA:N4CN) Change In Inventory : €-2.5 Mil (TTM As of Jun. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Paratek Pharmaceuticals Change In Inventory?

Paratek Pharmaceuticals's change in inventory for the quarter that ended in Jun. 2023 was €1.6 Mil. It means Paratek Pharmaceuticals's inventory declined by €1.6 Mil from Mar. 2023 to Jun. 2023 .

Paratek Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2022 was €-8.6 Mil. It means Paratek Pharmaceuticals's inventory increased by €8.6 Mil from Dec. 2021 to Dec. 2022 .

Paratek Pharmaceuticals's Total Inventories for the quarter that ended in Jun. 2023 was €10.5 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Paratek Pharmaceuticals's Days Inventory for the quarter that ended in Jun. 2023 was 267.12.

Inventory Turnover measures how fast the company turns over its inventory within a year. Paratek Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.34.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Paratek Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.34.

Paratek Pharmaceuticals Change In Inventory Historical Data

The historical data trend for Paratek Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paratek Pharmaceuticals Change In Inventory Chart

Paratek Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

-9.77

-9.67

-13.72

-8.58

Paratek Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Change In Inventory	Get a 7-Day Free Trial															-0.06	-8.20	5.65	-1.59	1.65

Paratek Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.5 Mil.

Paratek Pharmaceuticals (FRA:N4CN) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Paratek Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	11.8	/	4.031	*	365 / 4
	=	267.12

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Paratek Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	4.031	/	11.8
	=	0.34

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Paratek Pharmaceuticals's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	11.8	/	35.131
	=	0.34

Paratek Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of Paratek Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Paratek Pharmaceuticals (FRA:N4CN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Paratek Pharmaceuticals Inc (FRA:N4CN) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

75 Park Plaza, 4th Floor, Boston, MA, USA, 02116

Website

https://www.paratekpharma.com

Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's medical research is based on tetracycline chemistry and biology to create two antibacterials: omadacycline and sarecycline. NUZYRA (Omadacycline) is an antibacterial for skin infections and treatment of community-acquired bacterial pneumonia. SEYSARA (Sarecycline) is designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals is also involved in research to treat multiple sclerosis, spinal muscular atrophy, and systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases.

Paratek Pharmaceuticals (FRA:N4CN) Headlines

No Headlines